AAAAAA

   
Results: 1-21 |
Results: 21

Authors: Passa, P
Citation: P. Passa, Towards earlier and more aggressive insulin treatment in type 2 diabetic patients, DIABETE MET, 27(5), 2001, pp. S5-S6

Authors: Passa, P
Citation: P. Passa, The heart at the crossroad in the management of type 2 diabetic patients -Foreword, DIABETE MET, 27(5), 2001, pp. S5-S6

Authors: Le Floch, JP Marre, M Rodier, M Passa, P
Citation: Jp. Le Floch et al., Interest of Clinitek (R) microalbumin in screening for microalbuminuria: Results of a multicentre study in 302 diabetic patients, DIABETE MET, 27(1), 2001, pp. 36-39

Authors: Lievre, M Menard, J Bruckert, E Cogneau, J Delahaye, F Giral, P Leitersdorf, E Luc, G Masana, L Moulin, P Passa, P Pouchain, D Siest, G
Citation: M. Lievre et al., Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility, BR MED J, 322(7286), 2001, pp. 603-605

Authors: Ducimetiere, P Signeyrole, D Giral, P Hoog-Labouret, N Amarenco, P Chanu, B Chauvenet, M Coletti, M Dallongeville, J Durlach, V Kawka, G Krempf, M Leroux, G Mlika-Cabanne, N Monnier, L Paillard, F Rostoker, G Sicard, D Verny, C Voiriot, P Acquart, B Alquier, G Ankri, J Badoc, G Basdevant, A Belmin, J Berthezene, F Beucler, I Blanc, F Broustet, JP Bruckert, E Brun, JM Castaigne, A Charpentier, JM Andre, MC Cogneau, J Demeaux, JL Denolle, T Desson, JF Drahi, E Drouin, P Dumel, F Emmerich, J Farnier, M Fontbonne, A Forette, B Gambert, P Gautier, JC Guillausseau, PJ Hommel, M Janowski, M Le Goaziou, MF Lievre, M Le Quere, M Leys, D Marechaud, R Mas, JL Menard, J Michel, JM Mounier-Vehier, F Mottier, D Passa, P Pinel, JF Puel, J Raccah, D Renou, P Ribier, A Schlienger, JL Thomas, D Vallee, JP Veyssier-Belot, C Bouvenot, G Abadie, E Alexandre, JM Belorgey-Bismut, C Bergmann, JF Camelli, B Caulin, C Costagliola, D Denis, C Dupuis, B Fleurette, F Guillevin, L Hoog-Labouret, N Paintaud, G Rauss, A Poynard, T Rostoker, G Wong, O
Citation: P. Ducimetiere et al., The AFSSAPS recommendations for good practice: Therapeutic management of patients with dyslipidemia., J MAL VASC, 26(2), 2001, pp. 105-110

Authors: Passa, P
Citation: P. Passa, Therapeutic aspects of primary prevention of cardiovascular disease, ANN ENDOCR, 62(4), 2001, pp. 280-283

Authors: Passa, P
Citation: P. Passa, Diabetic nephropathy: What are the diabetologist's expectations?, DIABETE MET, 26, 2000, pp. 6-6

Authors: Charbonnel, B Passa, P
Citation: B. Charbonnel et P. Passa, Blood glucose peaks: An update - Diabete-Grenoble 2000 - Bayer Pharma, Satellite Symposium, 23th Marth 2000, DIABETE MET, 26, 2000, pp. 5-5

Authors: Grimaldi, A Grange, V Allannic, H Passa, P Rodier, M Cornet, P Duprat, T Duc-Dodon, P Lemaire, A Liard, F Eschwege, E
Citation: A. Grimaldi et al., Epidemiological analysis of patients with Type 2 diabetes in France, J DIABET C, 14(5), 2000, pp. 242-249

Authors: Hadjadj, S Gallois, Y Simard, G Bouhanick, B Passa, P Grimaldi, A Drouin, P Tichet, J Marre, M
Citation: S. Hadjadj et al., Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein, NEPH DIAL T, 15(12), 2000, pp. 1971-1976

Authors: Marre, M Lievre, M Vasmant, D Gallois, Y Hadjadj, S Reglier, JC Chatellier, G Mann, J Viberti, GC Passa, P
Citation: M. Marre et al., Determinants of elevated urinary albumin in the 4,937 type 2 diabetic subjects recruited for the DIABHYCAR Study in Western Europe and North Africa, DIABET CARE, 23, 2000, pp. B40-B48

Authors: Lacquemant, C Gaucher, C Delorme, C Chatellier, G Gallois, Y Rodier, M Passa, P Balkau, B Mazurier, C Marre, M Froguel, P
Citation: C. Lacquemant et al., Association between high von Willebrand factor levels and the Thr789Ala VWF gene polymorphism but not with nephropathy in type 1 diabetes, KIDNEY INT, 57(4), 2000, pp. 1437-1443

Authors: Rerolle, JP Thervet, E Desgrandchamps, F Nochy, D Janin, A Fornairon, S Passa, P Bedrossian, J Legendre, C
Citation: Jp. Rerolle et al., Histologic evolution of kidney graft after combined pancreas-kidney transplantation, TRANSPLAN P, 32(2), 2000, pp. 423-424

Authors: James, RW Leviev, I Ruiz, J Passa, P Froguel, P Garin, MCB
Citation: Rw. James et al., Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients, DIABETES, 49(8), 2000, pp. 1390-1393

Authors: Passa, P
Citation: P. Passa, How many diabetic patients in France?, DIABETE MET, 25(4), 1999, pp. 366-367

Authors: Brun, JM Passa, P Sauvanet, JP Berthezene, F Komajda, M
Citation: Jm. Brun et al., Proceedings of the annual symposium organised by the ALFEDIAM in conjunction with the Societe Francaise de Cardiologie and the ARCOL held in Paris, France, December 4, 1998 - Foreword, DIABETE MET, 25, 1999, pp. 5-6

Authors: Passa, P
Citation: P. Passa, Should the coronary diabetic patient benefit from specific management? Theviewpoint of the diabetologist., DIABETE MET, 25, 1999, pp. 58-64

Authors: Charbonnel, B Aptel, I Amouyel, P Attali, JR Aulanier, S Balarac, N Bukowski, JV Cathelineau, B de Broucker, T Denis, C Mausset, J Ormieres, JJ Passa, P Paulhan, A Pousset, F Pouteil-Noble, C Laversin, S Anouchian, P Aquino, JP Aubert, JP Baufine-Ducrocq, H Bernard, MH Bonnet, A Chabassol, E Cirioni, A Colas, C Cordonnier, D Coscas, G Cuvelier, D Dany, F Derrien, G Desrousseaux, B Dueymes, JM Dupasquier, JP Dussart, L Gemez-Lestradet, C Gerson, M Grimaldi, A Gros, M Guerot, C Guyot-Argenton, C Halimi, S Kourilsky, O Laneelle, D Laudet, J Lelong, S Malinsky, M Meffre, C Moulin, P Olaya, E Razongles, P Said, G Vague, P
Citation: B. Charbonnel et al., Follow-up of type 2 diabetes patients (excluding complications), PRESSE MED, 28(19), 1999, pp. 1023-1027

Authors: Passa, P
Citation: P. Passa, Reducing the cardiovascular consequences of diabetes mellitus, DIABET MED, 15(12), 1998, pp. S69-S72

Authors: Passa, P
Citation: P. Passa, Reducing the cardiovascular consequences of diabetes mellitus, DIABET MED, 15(12), 1998, pp. S69-S72

Authors: Passa, P
Citation: P. Passa, Cardiovascular risk and diabetes., ANN ENDOCR, 59(4), 1998, pp. 329-333
Risultati: 1-21 |